Sutro Biopharma (STRO) Treasury Shares (2016 - 2018)

Sutro Biopharma has reported Treasury Shares for 10 years, with the latest figure at $417772.0 in Q4 2025.

• Quarterly Treasury Shares fell 29.87% year-over-year to $417772.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $417772.0 (down 29.87% YoY) and the FY2025 annual result came in at $417772.0, down 29.87% from the prior year.
• Treasury Shares slipped to $417772.0 in Q4 2025 per STRO's latest filing, from $5.2 million in the prior quarter.
• Over five years, Treasury Shares peaked at $6.2 million in Q2 2025 and troughed at $417772.0 in Q4 2025.
• A 5-year average of $4.0 million and a median of $3.9 million in 2022 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2021 and 2024: Treasury Shares jumped 260.73% in 2021, then plunged 88.64% in 2024.
• Over 5 years, Treasury Shares stood at $2.4 million in 2021, then soared by 64.67% to $4.0 million in 2022, then jumped by 32.5% to $5.2 million in 2023, then slumped by 88.64% to $595691.0 in 2024, then fell by 29.87% to $417772.0 in 2025.
• According to Business Quant data, Treasury Shares over the past three periods registered $417772.0, $5.2 million, and $6.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.